(Q35863400)

10 August 2017

1 reference

title

Depression in Parkinson's disease: conceptual issues and clinical challenges (English)

1 reference

10 August 2017

1 reference

Albert F G Leentjens

1

1 reference

10 August 2017

1 September 2004

1 reference

Journal of Geriatric Psychiatry and Neurology

10 August 2017

1 reference

10 August 2017

17

1 reference

10 August 2017

120-126

1 reference

10 August 2017

3

1 reference

Neuropsychiatric aspects of Parkinson's disease

10 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Depression and Parkinson's disease: a conceptual challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Neurology and psychiatry: closing the great divide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Organic unity theory: the mind-body problem revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

A new intellectual framework for psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Evidence for atypical depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Depression in Parkinson's disease: a quantitative and qualitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

The pattern of depressive symptoms varies with progression of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

The contribution of somatic symptoms to the diagnosis of depressive disorder in Parkinson's disease: a discriminant analytic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

The occurrence of depression in Parkinson's disease. A community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Review of community prevalence of depression in later life

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Depression and Parkinson's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Disease-specific properties of the Rating Scale for Depression in patients with stroke, Alzheimer's dementia, and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Higher incidence of depression preceding the onset of Parkinson's disease: a register study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Increased risk of Parkinson's disease after depression: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Depression and the development of cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Mood disorders and allostatic load

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Depression and disability in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Risk factors for depression in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Temporal lobe dysfunction and correlation of regional cerebral blood flow abnormalities with psychopathology in schizophrenia and major depression--a study with single photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

The neuropsychiatry of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Altered serotonin metabolism in depressed patients with parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Central serotonin metabolism and frequency of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Movement Disorders Associated With the Serotonin Selective Reuptake Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Selective serotonin-reuptake inhibitor-induced movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

A cholinergic-adrenergic hypothesis of mania and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Donepezil in treatment-resistant bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Monoamines and abnormal behaviour. A multi-aminergic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

The balance of biogenic amines as condition for normal behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Mirthful laughter induced by subthalamic nucleus stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Mania following deep brain stimulation for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: a functional MRI case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Measuring the impact of Parkinson's disease with the Parkinson's Disease Quality of Life questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

The correlation of depression with functional activity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Treatment of depression in Parkinson's disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

SSRIs in the treatment of depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Bupropion in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Effectiveness of ECT in patients with parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Electroconvulsive therapy for the physical signs of Parkinson's disease without depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Electroconvulsive therapy in Parkinson's disease: 30 month follow up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267456

21 January 2018

Identifiers

DOI

10.1177/0891988704267456

1 reference

10 August 2017

1 reference

PubMed ID

15312275